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Primary health careWe examined the readiness of primary care clinicians to implement lung cancer screening programs in their
practice settings in light of recent policy changes in the U.S.
Attendees of two large continuing medical education events in Texas held in October and November of 2014
completed surveys about their current lung cancer screening practices and implementation needs.
Surveyswere completed by 350 participants (57.2% of registered attendees). Although 89.5% of participants rou-
tinely screened their patients for tobacco use, only 10.1% had a formal lung cancer screening program in their
practice. More than half (56.0%) planned to refer eligible patients for lung cancer screening, 35.6% were not
sure, and 8.3% did not plan to refer. Priority areas for implementing lung cancer screening programs in their set-
tings included 1) greater clarity about coverage by private insurance and Medicare, 2) information about avail-
able screening centers offering low-dose computed tomography, 3) patient education and shared decision-
making tools, 4) implementation toolkits and training for clinic staff, 5) integrating screening programs in elec-
tronic health records, and 6) more clarity about clinical guidelines.
Practical needs related to identifying eligible patients, referral to screening centers, and tools for shared decision-
making must be addressed before lung cancer screening can be implemented on a national scale.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The United States Preventive Services Task Force (USPSTF) recently
endorsed (grade B recommendation) lung cancer screening with low-
dose computed tomography (LDCT) for high-risk current and former
smokers aged 55–80 years with no history of lung cancer (Moyer,
2014) The Patient Protection and Affordable Care Act mandates ﬁrst-
dollar coverage for grades A and B USPSTF recommendations (Woolf
and Campos-Outcalt, 2013). The Centers for Medicare and Medicaid
Services (CMS) has issued a national coverage decision for theMedicare
population, endorsing lung cancer to the age of 77 years with additional
eligibility requirements for beneﬁciaries, radiologists, and radiology
imaging centers (Centers for Medicare & Medicaid Services, 2015).
The CMS decision requires a lung cancer screening counseling and
shared decision-making visit, including the use of patient decision
aids, and a written referral order from a qualiﬁed health care provider.
In contrast to the USPSTF recommendation, the American Academy
of Family Physicians concluded that there was insufﬁcient evidence to
recommend for or against screening for lung screening with low-doseices Research, The University of
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. This is an open access article undercomputed tomography (grade I recommendation) (American Academy
of Family Physicians, 2013). Principal concerns noted by the American
Academy of Family Physicians include the ability to replicate ﬁndings
from the National Lung Screening Trial (Aberle et al., 2011) in commu-
nity settings, the unknown long-term harms of radiation exposure from
screening and follow-up testing, the use of modeling by the USPSTF to
extend the screening interval and upper age limit, and a lack of a cost-
beneﬁt analysis. Like the USPSTF and CMS, the American Academy of
Family Physicians endorses a shared decision-making discussion
between the clinician and patient about the beneﬁts and potential
harms of lung cancer screening.
Recent policy changes place primary care clinicians at the forefront
in implementing lung cancer screening programs nationally (Mulshine
and D'Amico, 2014). We surveyed primary care clinicians attending
annual continuing medical education (CME) events in Texas about
their current practice and readiness to implement lung cancer screening
programs in their practice settings.
Methods
Attendees of 2 large primary care CME events in October and
November 2014 completed anonymous surveys about their practice
and priorities for establishing a lung cancer screening program and
knowledge of current clinical practice guidelines. The timing of the
study fell after the USPSTF updated recommendation was released andthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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USPSTF guidance on elements of a structured lung cancer screening
program was used to assess current practice, with response options of
“yes,” “no,” or “unsure” (Richards et al., 2014). Survey results about cur-
rent lung cancer screening activities were stratiﬁed bywhether the pri-
mary care clinician's practice was a residency training site. We felt that
stratiﬁcation by training site was warranted because these programs
have educational activities such as journal clubs where new research
evidence and guidelines might be discussed. Participants were also
asked “What would bemost helpful to you in implementing a lung can-
cer screening program in your practice (if you don't already have one)?”
Their responses to this open-ended question were reviewed by the
research team and collapsed into broad priority areas. Consensus was
reached for any areas that were initially coded inconsistently. From
there, the frequencies of the speciﬁc priority areas were tabulated. For
the participants, practice settings and years since completion of residen-
cy training were compared to the broader membership of the Texas
Academyof Family Physicians. Theprojectwas approved by TheUniver-
sity of Texas MD Anderson Cancer Center Institutional Review Board.
Results
Surveys were returned by 354 of 612 registered attendees; 3 retired
physicians and 1 oncologist were excluded, leaving 350 participants
(57.2% of registered attendees). Specialty was listed as family medicine
by 333 participants (95.1%); 3 were physicians practicing in emergency
or urgent care settings; and 2 were physician assistants. For 11 partici-
pants, their practice location was outside of Texas. Sixty-one counties
within Texas were represented by the participants' practice locations.
No differences in clinician or practice characteristics were observed
across the 2 CME events. The number of years since completing residen-
cy training was similar among participants as among members of the
statewide Texas Academy of Family Physicians, but participants were
less likely to practice in emergency departments or urgent care clinics
(.9%) than members (9%).
The majority (301, 86%) reported being somewhat or very familiar
with current guidelines about lung cancer screening from the USPSTF
and American Academy of Family Physicians. Although 89.5% of partic-
ipants routinely screened for tobacco use, only 10.1% had a formal lung
cancer screening program in their practice. More than half (194, 56.0%)
planned to refer eligible patients for lung cancer screening, 35.6% (124)
were not sure, and 8.3% (29) did not plan to refer.
As shown in Table 1, less than half of participants were currently re-
ferring patients to high-quality screening programs, had systems to
identify eligible patients for screening, or engaged patients in informed
or shared decision-making about lung cancer screening. More common
were activities around follow-up of patients with abnormal screening
ﬁndings, management of other health problems for patients with lung
cancer, and provision of smoking cessation services. Two areas were
signiﬁcantly less common among primary care clinicians who do
not train residents compared to those who do: referring patients toTable 1
Current lung cancer screening practices by primary care clinicians (PCCs).
Characteristic of a structured lung cancer screening program PCCs from prac
training sites (
Identify patients eligible for screening 24 (43.6)
Engage patients in shared or informed decision-making prior to referral 24 (44.4)
Refer patients to high-quality “certiﬁed” screening programs 22 (43.1)
Follow-up with patients who have abnormal ﬁndings 45 (81.8)
For patients diagnosed with lung cancer, manage their other health
problems during treatment
51 (91.1)
Provide tobacco treatment services for smokers 53 (94.6)
Characteristics of lung cancer screening programs are adapted from Richards et al. (2014). Per
a P values are from chi-square tests.screening centers and following up with patients who have an
abnormal screening ﬁnding.
Priority areas for implementing lung cancer screening programs are
given in Table 2, in rank order of prevalence. Of the 335 participants
who did not currently have a lung cancer screening program in their
practices, 113 (33.7%) offered responses about priority areas for imple-
mentation. The three top priority areas were 1) clarity about coverage
for screening, 2) information about available screening centers offering
LDCT, and 3) patient decision aids and educational materials. Imple-
mentation toolkits were noted, along with strategies to integrate lung
cancer screening in current electronic health records, training for staff,
and clarity about current guidelines. Several clinicians mentioned
ongoing concerns about the quality of the evidence supporting lung
cancer screening and the potential high health care costs associated
with a national program.
Discussion
Primary care clinicians will play a crucial role in lung cancer screen-
ing as it rolls out in the U.S. Although a substantial number of primary
care clinicians are uncertain about referring patients for lung cancer
screening, few currently reject it outright. These ﬁndings are notewor-
thy given the cautious position of the American Academyof Family Phy-
sicians and concerns about the validity of the available evidence about
screening in persons 65 and older (Woolf et al., 2014). Logistical consid-
erations surrounding implementation of lung cancer screening in their
practice settings remain major concerns of primary care clinicians, and
provider and patient education will be needed to ensure high-quality
screening occurs (Hoffman et al., 2015).
There is good reason to expect that lung cancer screening will be
adopted by primary care clinicians in the U.S. as the logistical concerns
around implementation are addressed. A national survey of practicing
primary care clinicians conducted in 2006 and 2007, a period when
guidelines did not endorse lung cancer screening, showed that the ma-
jority of clinicians were screening their asymptomatic patients for lung
cancer with chest radiography despite a lack of evidence supporting its
beneﬁt (Klabunde et al., 2012). These same clinicians had favorable be-
liefs about the efﬁcacy of low-dose CT for reducing mortality from lung
cancer. Yet, adoption of lung cancer screeningwill likelymeetwith chal-
lenges beyond logistical concerns including the potential for patients'
expectations about screening to be in conﬂict with clinicians' concerns
about harms and costs (Henderson et al., 2011). It seems reasonable
that some primary care clinicians will not recommend lung cancer
screening until the risk-to-beneﬁt ratio and costs considerations
become more favorable.
Lung cancer screening is now a covered preventive service in theU.S.
through private insurance andMedicare for eligible patients. Identifying
high-quality lung cancer screening centers remains a challenge given a
lack of uniformity around current screening practices (Boiselle et al.,
2014). The American College of Radiology and Lung Cancer Alliance
have implemented certiﬁcation programs for centers offering low-
dose CT screening for lung cancer (American College of Radiology,tices that serve as residency
n = 58), No. (%)
PCCs from practices that do not
train residents (n = 292), No. (%)
P valuea
92 (32.9) .25
119 (42.5) .97
69 (25.0) .03
169 (62.1) .02
241 (85.2) .34
253 (88.8) .37
centages are based on valid responses excluding missing data.
Table 2
Priority areas for lung cancer screening implementation as reported by primary care
clinicians (PCCs).
Priority area No.
Clarity on insurance/Medicare coverage for lung cancer screening. 30
Help ﬁnding lung cancer screening centers for patient referral. 23
Patient education/patient decision aids. 19
Implementation toolkits/general guidance on implementation strategies. 13
Integration of lung cancer screening programs within electronic health
records.
11
Clarity about current lung cancer screening guidelines for professional
organizations.
10
Concerns about costs, harms, and quality of evidence. 7
Training for clinic staff. 6
Responses are to the question, “What would be most helpful to you in implementing a
lung cancer screening program in your practice (if you don't currently have one)?” Of
335 participantswho did not currently have a lung cancer screening program, 113 offered
at least 1 comment. The counts do not sum to 113 because respondents could indicate
more than on priority area.
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decision-making interventions, including patient decision aids that
meet international standards for development and content, are acutely
needed (Joseph-Williams et al., 2013).
This study is limited to primary care clinicians largely from Texas,
and we do not know how current practice might differ for clinicians in
other areas of the U.S. Similarly, we do know how rapidly primary
care clinicians in Texas adopt newpractice guidelines compared to clini-
cians outside of Texas. Despite a participation rate approaching 60%, we
cannot rule out response bias due to interest in the lung cancer screen-
ing topic. We did not include an objective assessment of knowledge of
current screening guidelines. It is reassuring that most primary care cli-
nicians currently provide tobacco treatment services for their patients,
but we do not have information about the type or quality of services
being used. Intentions to refer patients for lung cancer screening were
assessed using responses to a single question, andmore in-depth explo-
ration of clinicians' attitudes about screening is warranted (Hoffman
et al., 2015). A related concern is that we did not directly assess
clinicians' beliefs regarding the effectiveness of lung cancer screening,
and this area is worthy of additional research as lung cancer screening
rolls out nationally. Finally, about one-third of the clinicians responded
to our question about priority areas for implementation and we do not
know if the other clinicians shared these priorities.
Conclusion
Primary care clinicians are generally receptive to referring eligible
patients for screening, but they have practical needs related to estab-
lishing structured programs in their settings that must be addressed
before screening is implemented on a broad scale.
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